Consensus on the Development of Vaccines against Naturally Acquired Melioidosis

Consensus on the Development of Vaccines against Naturally Acquired Melioidosis

Several candidates for a vaccine against Burkholderia pseudomallei, the causal bacterium of melioidosis, have been developed, and a rational approach is now needed to select and advance candidates for testing in relevant nonhuman primate models and in human clinical trials. Development of such a vac...

Full description

Bibliographic Details
Main Authors: Direk Limmathurotsakul, Simon G.P. Funnell, Alfredo G. Torres, Lisa A. Morici, Paul J. Brett, Susanna Dunachie, Timothy Atkins, Daniel M. Altmann, Gregory Bancroft, Sharon J. Peacock
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2015-06-01
Series:Emerging Infectious Diseases
Subjects:
Burkholderia pseudomallei
melioidosis
Whitmore’s disease
bacteria
vaccine
antimicrobial drugs
Online Access:https://wwwnc.cdc.gov/eid/article/21/6/14-1480_article

Internet

https://wwwnc.cdc.gov/eid/article/21/6/14-1480_article

Similar Items